NORTHBROOK, Ill., June 28, 2012 -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that the U.S. Food and Drug ...
Most Medicare drug plans cover the cost of mirabegron (Myrbetriq). But you’ll likely still have out-of-pocket costs. Many of the discount coupons available cannot be used with Medicare. The price may ...
NORTHBROOK, Ill., Oct. 22, 2012 -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that MYRBETRIQ™ (mirabegron) ...
Lupin today announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), Mirabegron Extended-Release Tablets, 25 ...
Lupin Limited announced the launch of the United States Food and Drug Administration (FDA) approved mirabegron extended-release tablets, 25 mg in US markets. Mirabegron extended-release tablets, 25 mg ...
Myrbetriq will be supplied in 25 mg and 50 mg tablets and is expected to be available in pharmacies in the fourth quarter of 2012. Mirabegron was approved in Japan in July 2011, and regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results